Can HDL cholesterol be replaced by paraoxonase 1 activity in the prediction of severe coronary artery disease in patients with type 2 diabetes?
Abdolkarim Mahrooz, Omeh Farveh Khosravi-Asrami, Ahad Alizadeh, Neda Mohmmadi, Abouzar Bagheri, Zahra Kashi, Adele Bahar, Mani Nosrati, Mike Mackness
Topics & Concepts
Coronary artery diseaseParaoxonaseMedicineInternal medicineCholesterolCardiologyType 2 diabetesDiseaseDiabetes mellitusEndocrinologyOxidative stressParaoxonase enzyme and polymorphismsDiabetes, Cardiovascular Risks, and LipoproteinsAntiplatelet Therapy and Cardiovascular Diseases